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Summary
The Hippo (Hpo) tumor suppressor pathway regulates tissue
size by inhibiting cell proliferation and promoting apoptosis
[1–5]. The core components of the pathway, Hpo, Salvador,
Warts (Wts), and Mats, form a kinase cascade to inhibit the
activity of Yorkie (Yki), the transcriptional effector of the
pathway [6, 7]. Homeodomain-interacting protein kinases
(Hipks) are a family of conserved serine/threonine kinases
that function as regulators of various transcription factors
to regulate developmental processes including prolifera-
tion, differentiation, and apoptosis [8]. Hipk can induce
tissue overgrowth in Drosophila [9, 10]. We demonstrate
that Hipk is required to promote Yki activity. Hipk affects
neither Yki stability nor its subcellular localization. More-
over, hipk knockdown suppresses the overgrowth and
target gene expression caused by hyperactive Yki. Hipk
phosphorylates Yki and in vivo analyses show that Hipk’s
regulation of Yki is kinase-dependent. To our knowledge,
this is the first kinase identified to positively regulate Yki.
Results and Discussion
Hipk PromotesDrosophilaWingGrowth by Regulating Cell
Proliferation and Apoptosis
We have previously shown that excess homeodomain-inter-
acting protein kinase (Hipk) caused overgrowth in Drosophila
adult tissues [9, 10]. In the third-instar wing imaginal disc, ex-
pressing one or two copies of UAS-hipk using omb-Gal4 led
to dose-dependent overgrowth (Figures 1B and 1C), which
strikingly resembled the phenotype obtained when inhibiting
Hippo (Hpo) signaling by reducing warts (wts) or by overex-
pressing yorkie (yki) [6, 11, 12]. Conversely, reduction of Hipk
through mutation or double-stranded RNA-mediated knock-
down (hipkRNAi) leads to decrease of adult eye and wing size
[9, 10]. However, the cellular mechanisms that underlie Hipk’s
role in growth are unknown. Tissue overgrowth can result from
enhanced cell proliferation, decreased apoptosis, or both. We
performed immunohistochemistry with anti-phosphohistone
3 (PH3) and anti-cleaved Caspase 3 (Casp3) antibodies,
markers for mitosis and apoptosis, respectively. Ectopic
Hipk induced an increase in number of PH3-positive cells
(see Figures S1B and S1B’ available online). In contrast,
knockdown of hipk led to ectopic Casp3 staining (Figures
S1D and S1D’). Thus, Hipk can promote cell proliferation and
inhibits apoptosis to control the wing size.
Hipk Regulates the Expression of Yki Target Genes
In the absence of Hpo signaling, the TEAD/TEF family DNA-
binding transcription factor Scalloped (Sd) interacts with Yki*Correspondence: everheye@sfu.ca[13, 14] to initiate expression of the target genes, including
Drosophila inhibitor of apoptosis protein 1 (Diap1), cyclin
E (CycE), wingless (wg), and the Hpo agonist Expanded (ex)
[15–18]. yki overexpression leads to elevated levels of these
transcriptional targets and organomegaly [19]. Therefore, we
sought to examine whether Hipk regulates Yki-mediated
transcription.
Overexpressing hipk along the anterior-posterior (A/P)
boundary of the wing disc using patched (ptc)-Gal4 led to
ectopic expression of both Diap1-lacZ (Figure 1E) and CycE
(Figure 1G). In hipk4 mutant somatic clones, ex-lacZ ex-
pression was lost (arrows in Figures 1I and 1I’) and wg-lacZ
expression was reduced in the proximal region of the wing
pouch (arrows in Figures 1K and 1K’) where its expression is
regulated by the Hpo pathway [18], but not at the dorsal/
ventral boundary where its expression is Hpo-independent
(marked by an asterisk in Figures 1K and 1K’). These results
show that hipk can regulate the expression of several Yki
transcriptional targets.
Hipk Counteracts HpoGrowth Inhibition duringDrosophila
Wing Development
Because Yki is negatively regulated by the immediate
upstream regulator Wts, we examined the role of Hipk on
ex-lacZ expression in hipk, wts double-knockdown discs.
The upregulation of ex-lacZ seen following wts knockdown
in the posterior compartment of the wing disc (Figure 2B)
was prevented by simultaneous knockdown of hipk (Fig-
ure 2C). Thus, in this context, activated Yki requires Hipk for
its ability to initiate target gene expression. Further genetic
interaction studies extend and confirm the antagonistic
genetic interaction between hipk and members of the Hpo
pathway regulating Yki (Figure S2).
To assess whether the role of Hipk in regulating Yki target
genes was tissue specific, we examined expression of cyclin
E in the eye imaginal disc. In wtsx1 somatic clones (marked
by absence of GFP; Figures 2E and 2E’), CycE expression
was greatly expanded relative to wild-type (WT), due to dere-
pression of Yki (Figure 2D). In hipk4, wtsx1/+, wtsx1 loss of
function clones, the expansion of CycE is suppressed due to
reduced Hipk expression (Figures 2F and 2F’). This result
indicates that hipk is required for Yki target genes expression
in both wing and eye imaginal discs. Furthermore, coexpress-
ing WT yki and hipk promoted massive synergistic overgrowth
(Figure 2I) and induction of ex-lacZ (Figure 2I’) in comparison
to expressing yki (Figure 2G) or hipk alone (Figures S3M and
S3M’), implying that Hipk potentiates Yki activity to induce
growth. All these results together suggest a model that Hipk
promotes Yki-mediated growth and target gene expression.
Hipk Does Not Alter Yki Subcellular Localization
When Hpo signaling is activated, Wts phosphorylates Yki at
Serine 168, as well as two additional sites, Serine 111 and
250 [7]. As a result, Yki interacts with protein 14-3-3, leading
to Yki cytoplasmic retention [19, 20]. In the absence of phos-
phorylation by Wts and cytoplasmic retention, Yki can interact
with Sd, which promotes Yki nuclear localization and target
gene expression [13, 14, 21]. We speculated that Hipk might
Figure 1. Hipk Promotes Tissue Overgrowth and Regulates Yki Target Gene
Expression
(A) Control wing imaginal disc. One (B) or two (C) copies of HA-tagged
UAS-hipk were expressed using the omb-Gal4 driver.
(B and C) Anti-HA staining revealed the omb-Gal4 expression domain. Hpo
pathway target genes (Control expression patterns shown in D, F, H, and J)
were examined following hipk overexpression (E, E’, G, and G’) or hipk4
somatic clone generation (I, I’, K, and K’).
(D–E’) Diap1-lacZ expression.
(F–G’) Anti-CycE staining. (E, E’, G, and G’) ptc-Gal4was used to ectopically
express hipk:HA in the domain seen with anti-HA staining in (E’) and (G’).
(H–I’) ex-lacZ expression.
(J–K’) wg-lacZ expression. Asterisk indicates unaffected Wg expression at
the D/V boundary.
(I’ and K’) hipk4 loss-of-function clones are marked by the absence of GFP
(arrows). Also refer to Figure S1.
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1583be acting to regulate Yki nuclear localization or activity. The
activity of Yki, as measured by overgrowth phenotypes and
target gene expression, is consistently enhanced by Hipk,yet we found that the subcellular localization of exogenous
(Figures 2J and 2J’) or endogenous (Figures 3B and 3B’)
Yki following modulation of Hipk is unaltered, in comparison
to ex knockdown, which resulted in nuclear enrichment of
Yki (Figure S3B; [20]). In fact, we observe no difference in
Yki localization or levels despite a dramatic synergy with
Hipk in promoting growth and target gene expression (Figures
2I and 2I’).
To further explore the mechanism of Yki regulation, we
considered whether Hipk might act through any of its previ-
ously described targets. Hipk has been shown to regulate
the activity of targets including Slimb/b-TrCP, Armadillo
(Arm)/ b-catenin, and Groucho [9, 10, 22]. Recently, it was
shown that the Yki homolog Yes-associated protein (Yap) is
ubiquitinated by the SCFbTrCP E3 ubiquitin ligase, resulting in
Yap degradation [23]. Although the absence of a bTrCP-recog-
nition site in Yki argues against such a mechanism of control
by Hipk, we confirmed this by finding that knockdown of slimb
did not alter Yki protein levels (Figures S3C and S3C’) nor the
expression of Diap1-lacZ or ex-lacZ (Figures S3G and S3I’).Figure 2. Hipk Antagonizes theHpoPathway and
Promotes Yki Activity
ex-lacZ expression in (A) control, (B) hh >wtsRNAi,
(C) hh > wtsRNAi, hipkRNAi wing discs. hh-Gal4 is
expressed in the posterior compartment marked
with an asterisk, to the right of the dotted line.
CycE (red) expression in (D) control, (E and E’)
single wtsx1mutant clones, and (F and F’) double
hipk4, wtsx1 mutant clones in eye discs.
(E’ and F’) Mutant clones are marked by the
absence of GFP.
(D, E, and F) Arrowheads mark the location of the
morphogenetic furrow.
(G and G’) hh-Gal4 driving UAS-yki:GFP and (I
and I’) UAS-yki:GFP;UAS-hipk in wing discs,
stained for ex-lacZ and GFP to mark hh expres-
sion domain.
(H–J’) High magnification image of Yki locali-
zation (GFP) and nuclei (DAPI) in (H and H’)
hh > yki:GFP and (J and J’) hh > yki:GFP; hipk.
Also refer to Figure S2.
Figure 3. Hyperactive YkiS168A Requires Hipk to Promote Overgrowth and Target Gene Expression, whereas Yki Localization Is Unaffected by Modulation
of Hipk
(A–B’) Wing discs stained with anti-Yki (red) and DAPI (blue). en-Gal4was used to drive UAS transgenes in the posterior of the disc as indicated by expres-
sion of UAS-GFP (A’ and B’). Control disc is shown in (A) and (A’). en > GFP; hipkwt is shown in (B) and (B’). The arrowhead in (A) and (B) indicates the D/V
boundary.
(C’, D’, H’, and I’) ptc-Gal4 and hh-Gal4 expression domains are indicated byGFP expression. Expressing hyperactive Yki (Yki S168A:GFP) caused increased
expression of Wg (C and C’) and ex-lacZ (H and H’) accompanied by disc overgrowth.
(D, D’, I, and I’) hipk knockdown rescued the Yki S168A:GFP disc phenotype, Wg (D and D’) and ex-lacZ (I and I’) induction. Adult eyes from control (E), ptc >
ykiS168A:GFP (F), and ptc > hipkRNAi; ykiS168A:GFP (G). hipk reduction did not affect localization of YkiS168A shown as GFP expression with nuclear staining by
DAPI (blue) (L and L’). Anti-Yki stain (red in M and M’, detects all cellular Yki) showed that hipk knockdown did no change subcellular localization of either
YkiS168A or endogenous Yki. Noticeably, knocking down hipk (L, L’, M, and M’) decreased the number of cells expressing Yki S168A:GFP in comparison to
the number of cells seen expressing UAS-YkiS168A:GFP alone (J, J’, K, and K’). Also refer to Figure S3.
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Hpo and Wg/Wnt signaling [24–29]. To rule out that Hipk was
regulating Yki through its role in stabilizing Arm protein, we
examined wing phenotypes and ex-lacZ upon modulation of
Arm [9, 22]. Although activated Arms10 can induce over-
growths, they were not accompanied by ectopic Yki target
gene expression in contract to robust expansion of targets
and overgrowth seen with ectopic Hipk (Figures S3J–S3L’
and S3M). Therefore, we conclude that Hipk does not promote
Yki activity via its role in stabilizing Arm and promoting the
Wg pathway.
Lastly, we have found that Hipk can inhibit the transcrip-
tional corepressor Groucho (Gro) to promote Notch signaling
during Drosophila eye development [10]. Interestingly, we
observed that loss of hipk does not affect expression of the
Notch target Enhancer of split and Delta in the wing disc
(data not shown). This finding suggests that hipk does notregulate the Notch pathway in the Drosophila wing. To rule
out that the effect on Yki was due to Gro inhibition by Hipk,
we examined the effect of Gro on ex-lacZ and growth. Expres-
sion of gro caused reduction of both ex-lacZ expression and
growth that cannot be suppressed by coexpression of hipk
(Figures S3N–S3O’). Because Hipk cannot inhibit Gro in this
context, it is unlikely that Hipk promotes Yki indirectly via
Gro, although we cannot rule out completely that Gro may
compete with Yki for binding Hipk.
Hipk Regulates the Nuclear Activity of Yki
Based on the absence of a change in Yki subcellular localiza-
tion or protein levels due to Hipk modulation, we speculated
that Hipk regulates Yki activity at the nuclear level. To test
this model, we used a hyperactive form of Yki carrying a
serine-to-alanine mutation on serine 168 (YkiS168A:GFP), which
loses its ability to interact with 14-3-3, thus resulting in
Figure 4. Hipk Interacts with and Phosphorylates Yki and Its Kinase Activity
Is Required to Modulate the Hpo Target Genes In Vivo
(A) Hipk:Myc, Yki:HA, or HA alone were transfected into HEK293T cells.
Coimmunoprecipitation assays were performed with anti-HA antibodies,
and extracts were visualized by western blotting by using anti-Myc or
anti-HA antibodies to detect Hipk or Yki, respectively. For the negative
control, Hipk:Myc was not detected by pulling down HA protein (lane 4 in A).
(B) In an in vitro kinase assay using radiolabeled ATP, Yki:HA is phosphor-
ylated (indicated as p-Yki) in the presence of Hipk:HA (lane 4), but not in
its absence (lane 3) or when incubated with kinase-dead (KD) Hipk (lane
5). Hipk autophosphorylation (p-Hipk) serves as a positive control in lanes
1 and 4.
(C–D’)Diap1-lacZexpression in (C)ptc>hipkwt:HAand (D,D’)ptc>hipkKD:HA
wing discs.
(E–F’) ex-lacZ expression in (E) hh > hipkwt:HA and (F, F’) hh > hipkKD:HA
wing discs. Expression of hipkKD (D, D’, E and E’) is shown by anti-HA stain-
ing. Also refer to Figure S4.
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1585enhanced nuclear localization and activity [19, 20]. Expression
of UAS-ykiS168A: GFP using hh-Gal4 induced massive over-
growth and expression of ex-lacZ (Figure 3H). Similarly,
ptc-Gal4 driven UAS-ykiS168A: GFP induced overgrowth and
Wg expression in the proximal region of the wing pouch (arrow
in Figure 3C), as well as prompted overgrowth in the wing disc
(Figure 3C), eye (Figure 3F), leg, and haltere (data not shown).
Remarkably, knocking down hipk in this genetic context
rescued the overgrowth phenotype in all tissues examined
(Figures 3D, 3G, 3I), as well as suppressed Wg and ex-lacZ
induction (Figures 3D and 3I), suggesting that Hipk may act
as a general regulator of Yki. Furthermore, hipk knockdown
did not affect subcellular localization of YkiS168A:GFP (Fig-
ure 3L) or total Yki (Figure 3M) but did cause a reduction in
cell proliferation, as seen by a decrease in number of
YkiS168A:GFP-expressing cells (compare Figures 3J and 3L).
Moreover, hipk knockdown rescued the lethality caused
by overexpressing Yki S111A, S168A, S250A (data not shown),
which carries phosphoresistant mutations on all three Wtsphosphorylation sites [7]. These findings support the model
that Hipk promotes Yki transcriptional activity within the
nucleus.
Hipk Regulation of Yki Activity Is Kinase-Dependent
To investigate a mechanism underlying the regulation of Yki
activity, we performed coimmunoprecipitation and in vitro
kinase assays. In HEK293T cells transfected with Myc-tagged
Hipk and HA-tagged Yki, Hipk was coimmunoprecipitated in a
complex with Yki (Figure 4A, lane 2). Furthermore, we found
that Hipk phosphorylates Yki (Figure 4B, lane 4). Yki interacts
through its WW-domain with a number of components of
the Hpo pathway including Wts and Ex via binding to a PPxY
motif [30]. Hipk also possesses a conserved PPxY sequence
that may mediate the interaction with Yki.
The in vitro kinase assay shows that WT Hipk (Figure 4B,
lane 4; Figure S4, lane 2), but not kinase-dead (KD) Hipk
(Figure 4B, lane 5), phosphorylated Yki. To further determine
whether the kinase function of Hipk is required to promote
Yki activity, we used a KD form of hipk (UAS-hipkKD) to
examine Yki target expression in wing discs. Compared to
the potent effects seen with overexpressing WT hipk (Figures
4C and 4E), hipkKD was not able to induce ex-lacZ nor Diap1-
lacZ expression, nor to promote tissue overgrowth (Figures
4D, 4D’, 4F, and 4F’). These data indicate that Hipk requires
its kinase function to positively regulate Yki transcriptional
activity and to counteract the inhibition of Yki caused by Hpo
pathway members.
Our findings indicate that Hipk promotes Yki transcriptional
activity to regulate tissue growth during Drosophila develop-
ment. To the best of our knowledge, this is the first kinase
to positively regulate Yki by phosphorylation. Because Hipk
functions in multiple signaling pathways, we cannot com-
pletely eliminate the possibility that Hipk regulates Hpo
signaling and Yki via multiple pathways; however, we believe
that we have ruled out a regulation through known targets.
Furthermore, we show that Hipk phosphorylates Yki, implying
a direct regulatory role of Hipk on Yki. Although Hipk promotes
Yki activity by phosphorylation, the functional significance of
this modification has yet to be further investigated. In our anal-
yses, we have applied the same genetic criteria and obtained
similar results as were used to demonstrate that Sd was an
essential factor for Yki-mediated growth [13, 14, 21]. Given
that Hipk exerts its effects on nuclear Yki and is enriched in
nuclear speckles (data not shown [31]), it may play an impor-
tant role to facilitate the interactions between Yki and its tran-
scriptional cofactors. Further studies should reveal whether
this growth regulation byHipk familymembers is evolutionarily
conserved. Trapasso et al. demonstrate that hipk2 mutant
mice have a reduced body size and hipk22/2 mouse embryo
fibroblasts show reduced proliferation rates, suggesting that
Hipks may also promote Yap activity to regulate tissue growth
in vertebrates [32]. Using mammalian cell culture, we have
observed that overexpressing WT Hipk2, but not kinase-
dead Hipk2, is able to induce elevated Yap levels (data not
shown). This finding suggests that vertebrate Hipks may regu-
late Hpo signaling through Yap stability and possibly also by
regulating Yap nuclear activity.
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